Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
15/07/2026 06:30
BUZZ-Australia's Cyclopharm gains most in 8-months on Technegas rollout deal ** Shares of Australia's Cyclopharm CYC.AX rise as much as 35.1% to A$0.655, its biggest intraday pct gain since mid-November, 2025
** Stock at its highest level since June 4
** Radiopharmaceutical co secures agreement with University Hospitals, Cleveland, for commercial installation of Technegas across 11 clinical locations within hospital network
** Technegas is inhaled to help diagnose respiratory conditions
** Stock down 38.8% YTD, including session's moves
(Reporting by Subhalakshmi Dey in Bengaluru)
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair